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Objectives. Endoscopic management of bile leak after orthotopic liver transplant (OLT) is widely accepted. Preliminary studies
demonstrated encouraging results for covered self-expandable metal stents (CSEMS) in complex bile leaks. Methods. Thirty-one
patientswithpost-OLTbileleaksunderwentendoscopictemporaryplacementofCSEMS(3partiallyCSEMS,18fullyCSEMSwith
ﬁns and 10 fully CSEMS with ﬂare ends) between December 2003 and December 2010. Long-term clinical success and safety were
evaluated. Results. Median stent indwelling and follow-up were 89 and 1,353 days for PCSEMS, 102 and 849 for FCSEMS with ﬁns
and 98 and 203 for FCSEMS with ﬂare ends. Clinical success was achieved in 100%, 77.8%, and 70%, respectively. Postplacement
complications: cholangitis (1) and proximal migration (1), both in the FCSEMS with ﬁns. Postremoval complications were biliary
strictures requiring drainage: PCSEMS (1), FCSEMS with ﬁns (6) and with ﬂare ends (1). There was no signiﬁcant diﬀerences in
the FCSEMS groups regarding clinical success, age, gender, leak location, previous treatment, stent indwelling, and complications.
Conclusion. Temporary placement of CSEMS is eﬀective to treat post-OLT biliary leaks. However, a high number of post removal
biliary strictures occurred especially in the FCSEMS with ﬁns. CSEMS cannot be recommended in this patient population.
1.Introduction
Biliary complications are frequent after orthotopic liver
transplantation (OLT), aﬀecting 5 to 15% of patients after
deceased OLT and 28 to 32% after right-lobe living donor
OLT [1–4]. Post-OLT bile leaks are reported in 10 to 15% of
patients and are usually an early complication and represent
a high morbidity condition for the patient [5].
Endoscopictreatmentiswellrecognizedasﬁrst-linether-
apy in the management of post-OLT biliary leaks or stricture
[1, 4, 6, 7]. Endoscopic retrograde cholangiography (ERC)
with biliary sphincterotomy and/or transpapillary plastic
stent placement is typically oﬀered as standard treatment [8–
10]. Successful endoscopic therapy for postsurgical bile leaks
has been reported in 88 to 97% of cases and up to 83.9% in
those secondary to OLT [11].
Covered self-expandable metallic stents (CSEMSs) have
been increasingly used to treat benign biliary conditions and
have been shown promising results for both biliary strictures
and leakages [7, 12–14]. Their larger diameter, long-term
patency, and proven removability have turned them into an
appealing option to assess refractory and/or complex bile
leaks [7, 13–15].
Although few studies have already demonstrated encour-
aging results for CSEMS use in the treatment of postsurgical
bile leaks [13, 14], their long-term safety and eﬃcacy have
not been established for this particular group of patients
when compared to plastic stents. Indeed in order for CSEMS2 HPB Surgery
to replace plastic stents in this indication, not only they need
to demonstrate eﬃcacy but also long-term safety.
Therefore, the primary aim of this study was to review
our experience with temporary placement of three diﬀerent
types of CSEMS in the treatment of post-OLT biliary leaks.
2.MaterialsandMethods
We retrospectively reviewed a prospectively established data-
base to assess post-OLT bile leaks treated with CSEMS be-
tween December 2003 and December 2010.
Inclusioncriteriawerethesameaspreviouslydeﬁnedand
included patients with complex or high-grade leaks deﬁned
as those who failed endoscopic plastic stent therapy or with
severe comorbidities that prevented multiple procedures
who were referred to temporary placement of CSEMS [13].
One patient included in the PCSEMS group has been previ-
ously reported [13]. Data was captured prospectively as each
typeofstentcameonthemarketinchronologicalorder(ﬁrst
partially covered, then fully covered with ﬁns, after that fully
covered with ﬂared ends). Stent diameter was chosen de-
pending on diameter of the ducts to be drained.
Our endpoints were long-term clinical success (resolu-
tion of bile duct leak) and safety.
Our Institutional Review Board approved the study, and
written informed consent was obtained from all patients
prior to ERC.
2.1. Techniques of CSEMS Placement. A l lp r o c e d u r e sw e r e
eitherperformedorsupervisedbydedicatedbiliaryendosco-
pists performing at least 500 ERC yearly. ERC was performed
undergeneralanesthesiawithpatientsinthesupineposition.
Side-viewing endoscopes (TJF-140, TJF-160 and TJF-160VF,
O l y m p u sA m e r i c a ,C e n t e rV a l l e y ,P A ,U S A )w e r eu s e df o r
all procedures. Three diﬀerent types of CSEMS were placed:
partially CSEMS (PCSEMS) (Wallstent, Boston Scientiﬁc
Corp, Natick, MA, USA), fully CSEMS (FCSEMS) with ﬁns
(Viabil, Conmed, Utica, NY, USA) (Figure 1), and FCSEMS
with ﬂared ends (WallFlex, Boston Scientiﬁc Corp; Figure 2).
After selective biliary cannulation, biliary sphinctero-
tomywasperformed,andaretrievalballoonwasusedtoper-
form an occlusion cholangiogram and locate the bile leak
(Figure 3). Over the guidewire placed across the leak, the
CSEMS was deployed under ﬂuoroscopic control sealing the
leak (Figure 4). The stent was placed, crossing the papilla for
at least 1cm after deployment.
2.2. Deﬁnition of Events. Successful CSEMS placement was
deﬁned as deployment of the CSEMS across the leak with re-
solution of the leak ﬂuoroscopically. Proximal migration of
the FCSEMS was deﬁned as any migration of the CSEMS
into the bile duct. Distal migration was deﬁned as migration
of the stent into the duodenum from the transpapillary
position. Spontaneous CSEMS migration with resolution of
the leak was recorded but was not considered a complica-
tion. Post-stent-removal biliary strictures were deﬁned as a
narrowing demonstrated on imaging associated with elevat-
ed liver function tests.
Figure 1: Fully covered SEMS with antimigratory ﬁns.
Figure 2: Fully covered SEMS with ﬂare end and retrieval loop.
2.3. Followup after CSEMS Placement. All patients were seen
in our liver transplant clinic and digestive health center with
consultation of nephrology, pathology, or infectious diseases
whenever indicated. Short-term followup was obtained by a
clinic visit, with cross-sectional imaging one month after the
FCSEMSwasremoved.Laboratoryvalues,includingcomple-
te blood count and hepatic function panels, were also closely
followed. Long-term followup was obtained either by clinic
visit or telephone interview.
2.4. Technique of CSEMS Removal. After leakage resolution,
CSEMS was removed by using the rat tooth and/or snare
technique as previously described [16]. In cases where the
CSEMS had foreshortened or migrated within the bile duct,HPB Surgery 3
Figure 3: Anastomotic leak s/p liver transplant.
Figure 4: Fully covered SEMS deployed.
balloon dilation was used to disimpact the CSEMS with sub-
sequent rat tooth removal [17]. This was particularly impor-
tant whendealing with the partiallyCSEMS due tothe devel-
opmentoftissueovergrowthattheproximalportion,imbed-
ding the CSEMS or when removing the FCSEMS with ﬁns,
which anchor the CSEMS within the bile duct. The FCSEMS
has a loop at its distal end, which permits extraction using a
rat tooth, and, unless the loop was imbedded within the am-
pullary tissue, this technique was used preferentially.
Choledochoscopy was performed in patients whenever a
lesion or a stricture was suspected on ﬂuoroscopy following
CSEMS removal and used the single operator system (Spy-
Glass, Boston Scientiﬁc).
2.5. Data Collection and Statistical Analysis. Data was col-
lected from electronic medical records and our dedicated
procedure database. Data was captured prospectively on
all patients and analyzed retrospectively. Clinical response
to CSEMS placement and procedure-related morbidity and
mortality rates were analyzed.
SAS 9.2 (SAS Institute Inc. 2008, Cary, NC, USA) was
used for statistical analysis. Descriptive data were expressed
in means, medians, and standard deviations (SDs). Fischer’s
exact tests were conducted to observe any signiﬁcant diﬀer-
ences between stent groups, with the statistical signiﬁcance
set at P<0.05.
3. Results
During the study period a total of 451 transplants were per-
formed. A choledochocholedochostomy was performed in
428 patients (95%) while 23 patients received a roux anasto-
mosis (5%). Posttransplant leak was observed in 54 (12%)
patients and ischemic cholangitis in 23 (5%) patients.
Thirty-one patients underwent CSEMS placement for
bile leak treatment after deceased liver transplant, three in
thePCSEMSgroup,eighteenintheFCSEMSwithﬁnsgroup,
and ten in the FCSEMS with ﬂare ends group. Patients’ dem-
ographic characteristics are summarized in Table 1.T h e r e
was no evidence of signiﬁcant diﬀerences among them reg-
arding age, gender, leak site, time interval between OLT, and
procedure to CSEMS deployment and previous treatment
withplasticstent.Allpatientshadasingleduct-to-ductanas-
tomosis, and there was no reference to complex arterial re-
construction among patients treated in this series.
3.1. Partially CSEMS Group. Partially CSEMSs (80 mm
length) were temporary placed in three patients for a median
time of 89 days (range 55 to 110). After a median followup of
1,353 days (range 1,348 to 2,208), clinical success was achiev-
ed in all patients. There was one case of spontaneous migra-
tion, even though the patient had the leak resolved. Another
patient developed a late-onset hilar stricture, refractory to
bothendoscopicplasticstentingtherapyandunderwenthep-
aticojejunostomy. Choledochoscopy was performed for that
patient prior to surgery conﬁrming tissue overgrowth at the
hilum.
3.2. Fully CSEMS with Fins Group. In this group, 18 patients
underwent temporary placement of the FCSEMS with ﬁns
(80 and 100mm length) for a median of 102 days (range
35 to 427) and were followed after removal for a median of
849 days (range 323 to 1,111). Long-term leakage control
was achieved in 14 patients, 77.8% in an intention to
treat analysis. One patient died from unrelated cause, and
2 underwent liver retransplantation due to hepatic artery
thrombosis; by excluding them from the long-term analysis,
the clinical success rate would be 93.3% (14/15). One patient
presented cholangitis after stent deployment and was treated
with repeated ERC and plastic stent placement. Post-stent-
removalcomplicationsincludedsixclinicallysigniﬁcanthilar
biliarystricturesthatrequiredbiliarydrainage(6plasticwith
plastic stents, 2 with CSEMS, and 1 underwent a surgical
hepaticojejunostomy). Choledochoscopy was performed in
ﬁve patients and demonstrated ulcerations (Figure 5)i n4 HPB Surgery
Table 1: Patients demographics.
Type of stent PCSEMS FCSEMS with ﬁns FCSEMS with ﬂare
ends
N 3 18 10
Gender
Male 3 15 7
Age
(mean ± SD) 50 ±8.75 3 .9 ±5.05 6 ±6.7
Median (range) 40–56 42–60 48–69
Underlying liver disease
HCV 6 4
Ethanol 3 1
Cryptogenic 2 3 2
HCV + ethanol 2 2
HBV 1
NASH 1 1 1
Other 2
Post-OLT leak location
Anastomotic 1 (33.3%) 14 (77.8%) 7 (70%)
Nonanastomotic 2 (66.7%) 4 (22.2%) 3 (30%)
Time OLT to procedure (days)
Mean (SD) 36 (±8) 53.2 (±85.8) 22.9 (±16.4)
Median (range) 33 (29–45) 20 (6–328) 19 (5–63)
Previous plastic stenting
Yes 100% 3 (16.7%) 2 (20%)
T-tube 0 0 1 (10%)
OLT: orthotopic liver transplant, SD: standard deviation, HCV: hepatitis C virus; HBC: hepatitis B virus; others (hemochromatosis, alpha-1-antitrypsin).
PCSEMS: partially covered self-expanding metal stent, FCSEMS: fully covered self-expanding metal stent.
Figure 5: Ulceration seen during choledochoscopy after fully
covered SEMS removal.
4 patients (80%) that were managed conservatively and one
(20%) hilar stricture (Figure 6) that was treated with plastic
stenting.
3.3. Fully CSEMS with Flare Ends Group. Ten patients receiv-
ed a FCSEMS with ﬂare ends (80mm length). The CSEMS
Figure 6: Biliary stricture seen during choledochoscopy after fully
covered SEMS placement.
was kept in place for a median time of 98 days (range 96
to 139), and 3 patients still have the stent in situ. Median
followup after stent removal was 203 days (range 95 to 305),
and so far 70% (7/10) of patients presented clinical resolu-
tion of biliary leakage. One patient presented stent migra-
tion and spontaneous passage, with leak resolution. OneHPB Surgery 5
Table 2: Long-term evaluation of SEMS for the treatment of biliary leaks.
PCSEMS FCSEMS with ﬁns FCSEMS with ﬂare
ends
N 3 18 10
Stent in place (days)
Mean (SD) 85 (±28) 152.3 (±117.6) 106 (±19.7)
Median (range) 89 (55–110) 102 (35–427) 98 (96–139)
Stent diameter
8mm 0 2 5
10mm 3 16 5
Stent status
Stents removed 2 (66.7%) 13 (87%) 7 (70%)
Followup after removal (days)
Mean (SD) 1636.3 (±495.1) 797.9 (±261.9) 189.4 (±83.5)
Median (range) 1353
(1348–2208) 849 (323–1111) 203 (95–305)
Long-term success
Intention to treat 3/3 (100%) 14/18 (77.8%) 7/10 (70%)
Postplacement complications
Cholangitis 0 1/18 (5.6%) 0
Proximal migration 0 1/18 (5.6%) 0
Postremoval complications
Biliary stricture 1/3 (33.3%) 6/18 (35%) 1/10 (10%)
SD: standard deviation.
patient (10%) developed a hilar stricture after CSEMS
removal and received plastic stenting. Four patients under-
went choledochoscopy during stent removal, which revealed
inﬂammation in two patients (20%) and ulceration in one
(10%), but no hyperplasia.
3.4. Statistical Analysis. Fischer’s exact test was conducted to
analyze for diﬀerences in clinical success rates (leak resolu-
tion) among the FCSEMS groups. The PCSEMS group was
excluded due to a small number of patients. There was no
evidence of signiﬁcant diﬀerences in the 2 stent groups with
regards to clinical success, age, gender, leak location (anasto-
motic or non-anastomotic), previous treatment with plastic
stent, stent indwelling, postplacement, and post-removal
complications (all P>0.05). Followup was signiﬁcantly
longer in the FCSEMS with ﬁns group (P<0.01).
4. Discussion
Biliary leaks occur in 10 to 15% of patients after OLT and
usually present with clinical symptoms earlier than strictures
in the postoperative course [11]. They are typically classiﬁed
into anastomotic or nonanastomotic.
Endoscopy stands as a ﬁrst-line treatment for post-OLT
biliary leaks [11, 18]. However, many anastomotic leaks may
require surgical repair [11] and, therefore, have been deﬁned
as a complex leak [13, 14].
The main principle of endoscopic therapy for biliary
leakage is to reduce transpapillary pressure gradient via
transpapillary stenting with or without biliary sphinctero-
tomy; this is conventionally performed using plastic stents
[8, 9, 11].
With the large diameter provided by metal stent and the
ability to remove covered metal stents, the use of CSEMS in
bile leaks was the logical next step.
This was initially described by Baron and Poterucha [15],
when they reported 3 cases of complex bile leaks successfully
treated with CSEMS.
Promising results of CSEMS have also been further
reported by our team with long-term leak control obtained
in 87% (14/16) of patients with post-surgical bile leaks [13];
however, long-term results were not available yet.
CSEMSs have mainly been used as a rescue therapy for
patients who failed standard endoscopic therapy with plastic
stenting. However, more recently has been used as a ﬁrst-line
measure in patients with complex and high-grade leaks [19,
20].
The rationale to deploy a SEMS through a leak is to grant
the larger diameter possible allowing the patient to have the
faster recovery time, with fewer sessions, and prevent further
complications associated with the bile leak [21].
The median indwelling of CSEMS in this study was 189,
102, and 98 days, respectively, for the PCSEMS, the FCSEMS
with ﬁns, and the FCSEMS with ﬂare ends, respectively. The
use of CSEMS for the treatment of bile leak has the theoreti-
caladvantageofdecreasingthenumberofproceduresneeded
tocontroltheleakageinpatientswithcomplexorhigh-grade
ﬁstulas when compared to plastic stents. It is presumed that6 HPB Surgery
the initial increased cost associated with the use of CSEMS
will be compensated by the reduction of sessions required as
well as the days of hospitalization. This last point, however,
remains to be proven.
All patients in the partially CSEMS group had previously
failed plastic stenting (i.e., persistent leak after plastic stent
placement), and, after placement of the metal stent, leak
control was achieved in all of them (Tables 1 and 2).
Wallstent was the ﬁrst PCSEMS commercially available
in the US market but led to mucosal hyperplasia at its uncov-
ered portions and migration [12, 13]. Proximal migration is
especially problematic since it can be associated with hyper-
plasia and secondary stricture after stent removal. Distal
migration can lead to treatment failure.
Isayama et al. studied both radial (RF) and axial forces
(AF) of Wallstent and Viabil [21]. The results demonstrated
Wallstent to have high AF, possibly related to biliary wall
damage, kinking, and sludge formation and migration [21].
In the present study, distal migration was noted in one pa-
tient (33.3%) from PCSEMS and one (10%) from FCSEMS
with ﬂare ends group. This migration rate has been reported
in other studies [20, 22] and might be related to the respec-
tive force of the 2 CSEMSs, which are similar (Unpublished
data from Isayama).
The FCSEMS with anchoring ﬁns positioned at opposite
ends was designed to prevent migration [14]. It was found to
have a very high RF in Isayama et al. study, what might cause
an excessive high pressure to the biliary wall, resulting in in-
creasedtissueinjuryandeventualstricture[21].Inthisstudy,
tissue injury was found in 4/5 (80%) patients when choledo-
choscopy was performed in this group and an increased
number of post-stent-removal strictures (35%) that could
be a consequence of biliary compression and ischemia. Even
though migration rate was lower (5.6%), the increased num-
ber of postremoval stenosis is disencouraging.
A discussion is raised if the incidence of postremoval
strictures was related to the high radial force or to the pres-
ence of ﬁns that could stimulate tissue reaction and scarring.
Finally, FCSEMS with ﬂare ends was recently released
as fully covered SEMS, coated with premalume. It has a
retrieval loop and ﬂare ends to prevent migration. Although
the leakage controlled has been encouraging in this study, we
arestilldealingwithspontaneousdistalmigration(10%)and
postremoval stricture (10%).
Interestingly therenostatisticallysigniﬁcantdiﬀerence in
either group in term of ﬁnal outcome; this might be relat-
ed to a type 2 error, which can be overcome by increasing the
number of patients in each sample; however the complica-
tions’ rate associated with all three CSEMS does not justify
such a study.
Clearly, the ideal CSEMS for biliary leak is not available
yet. It probably needs to be fully covered with an inert and
resistantcoating andhasno ﬁns,whichseemto be associated
to signiﬁcant tissue reaction. Further CSEMS soon invading
the market might oﬀer those characteristics and need to be
carefully evaluated.
Inconclusion,temporaryplacementofCSEMSwaseﬀec-
tive to treat post-OLT biliary leaks. However, postremoval
biliary stricture requiring further endoscopic treatment was
seen especially with the FCSEMS with ﬁns group. At the
present time, CSEMS cannot be recommended in this pa-
tient population until major design changes have been made.
StudyHighlights
What is Current Knowledge. Post-OLT biliary leaks have high
morbidityrate,andendoscopictherapywithplasticstentcan
fail in up to 20% of patients.
What is New Here. Temporary placement of CSEMS is eﬀec-
tive to treat post-OLT biliary leaks. However, it is associated
with a high rate of biliary stricture.
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